Biotechnology companies play a vital role in advancing medical innovations and therapies, including breakthroughs and the development of novel therapies for various diseases.
The PRISM Emerging Biotech Index tracks small and micro-cap stocks that are contributing to healthcare innovation and economic growth.
| PRISM Biotech IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 2.69% | $132.05 | 32.05% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Equillium, Inc. | EQ | $1.32 | 1.54% | 511 | 807 | $84 | $0.73 | 79.76% |
| Immuron Limited | IMRN | $1.03 | 0.00% | 26 | 251 | $7 | $1.90 | -45.79% |
| Kamada Ltd. | KMDA | $7.83 | 3.03% | 61 | 44 | $452 | $6.16 | 27.11% |
| Achilles Therapeutics plc | ACHL | $1.48 | 0.68% | 1,204 | 1,282 | $61 | $0.87 | 69.72% |
| Adverum Biotechnologies, Inc. | ADVM | $4.36 | 0.00% | 676 | 724 | $96 | $0.83 | 426.51% |
| iBio, Inc. | IBIO | $0.78 | 0.26% | 347 | 956 | $50 | $1.38 | -43.48% |
| Palisade Bio, Inc. | PALI | $1.54 | 4.05% | 1,818 | 3,461 | $268 | $0.58 | 166.02% |
| BioLineRx Ltd. | BLRX | $2.05 | -1.20% | 29 | 54 | $10 | $1.53 | 33.99% |
| Immatics N.V. | IMTX | $7.14 | 2.00% | 1,628 | 478 | $1,068 | $10.72 | -33.40% |
| Vaxart, Inc. | VXRT | $0.46 | 0.00% | 44 | 391 | $112 | $0.61 | -24.47% |
| Capricor Therapeutics, Inc. | CAPR | $7.27 | 10.32% | 3,351 | 1,534 | $421 | $5.12 | 41.99% |
| Lisata Therapeutics, Inc. | LSTA | $1.07 | 4.90% | 23 | 108 | $10 | $2.78 | -61.51% |
| NeuroSense Therapeutics Ltd. | NRSN | $3.17 | 3.59% | 12 | 158 | $6 | $0.80 | 296.25% |
| Addex Therapeutics Ltd | ADXN | $3.02 | 13.96% | 36 | 4 | $4 | $6.30 | -52.05% |
| Metagenomi, Inc. Common Stock | MGX | $0.85 | -1.86% | 291 | 181 | $32 | $10.31 | -91.76% |
| Annexon, Inc. | ANNX | $3.60 | -1.91% | 2,629 | 3,508 | $590 | $4.84 | -25.62% |
| Rezolute, Inc. | RZLT | $3.90 | -7.80% | 2,117 | 1,887 | $377 | $1.02 | 284.24% |
| Foghorn Therapeutics Inc. | FHTX | $1.89 | 2.16% | 347 | 245 | $112 | $8.45 | -77.63% |
| Innate Pharma S.A. | IPHA | $1.48 | 3.50% | 7 | 68 | $158 | $5.72 | -74.13% |
| Chemomab Therapeutics Ltd. | CMMB | $1.29 | 0.00% | 22 | 129 | $8 | $0.54 | 139.87% |
| Cerenome, Inc. | CNSY | $1.88 | 11.24% | 112 | 0 | $14 | $1.85 | 1.62% |
| Ardelyx, Inc. | ARDX | $3.27 | 2.51% | 4,066 | 4,027 | $814 | $6.05 | -45.95% |
| Eupraxia Pharmaceuticals Inc. | EPRX | $6.77 | 2.73% | 593 | 307 | $227 | $4.16 | 62.69% |
| Taysha Gene Therapies, Inc. | TSHA | $3.73 | 6.27% | 4,529 | 3,039 | $1,212 | $1.71 | 118.13% |
| Entrada Therapeutics, Inc. | TRDA | $4.78 | 5.05% | 515 | 466 | $186 | $15.17 | -68.49% |
| Akebia Therapeutics, Inc. | AKBA | $0.70 | -0.93% | 8,851 | 5,065 | $193 | $1.27 | -44.88% |
| Enliven Therapeutics, Inc. | ELVN | $39.33 | 0.13% | 2,053 | 1,306 | $2,882 | $14.90 | 163.96% |
| TG Therapeutics, Inc. | TGTX | $56.00 | 3.00% | 1,808 | 2,412 | $8,573 | $17.04 | 228.64% |
| Myriad Genetics, Inc. | MYGN | $4.35 | 4.82% | 1,068 | 1,619 | $416 | $19.00 | -77.11% |
| Ocular Therapeutix, Inc. | OCUL | $7.38 | 2.50% | 3,252 | 2,743 | $1,621 | $4.81 | 53.43% |
| Actuate Therapeutics Inc | ACTU | $0.50 | 15.13% | 472 | 251 | $12 | $8.61 | -94.19% |
| Shattuck Labs, Inc. | STTK | $5.53 | 3.75% | 868 | 1,238 | $555 | $7.56 | -26.85% |
| Abeona Therapeutics Inc. | ABEO | $4.65 | 6.65% | 1,377 | 1,237 | $265 | $5.61 | -17.11% |
| ProKidney Corp. | PROK | $1.46 | -1.02% | 1,107 | 1,125 | $489 | $1.73 | -15.61% |
| uniQure N.V. | QURE | $22.52 | 7.39% | 1,608 | 2,161 | $1,562 | $17.85 | 26.16% |
| Evommune, Inc. | EVMN | $5.93 | 2.77% | 579 | 782 | $215 | $17.32 | -65.76% |
| Ocugen, Inc. | OCGN | $0.81 | -3.27% | 5,918 | 7,595 | $276 | $1.36 | -40.44% |
| Prelude Therapeutics Incorporated | PRLD | $3.32 | 2.79% | 400 | 442 | $192 | $2.90 | 14.48% |
| Tango Therapeutics, Inc. | TNGX | $22.70 | 2.30% | 2,904 | 4,084 | $3,827 | $8.85 | 156.50% |
| Pyxis Oncology, Inc. | PYXS | $1.80 | 0.56% | 546 | 931 | $114 | $1.18 | 52.54% |
| Nuvation Bio Inc. | NUVB | $4.75 | 1.60% | 4,823 | 6,412 | $1,663 | $2.89 | 64.36% |
| Korro Bio, Inc. | KRRO | $9.31 | 4.84% | 440 | 192 | $137 | $42.84 | -78.27% |
| Talphera, Inc. | TLPH | $1.07 | 0.94% | 35 | 276 | $56 | $1.14 | -6.14% |
| BridgeBio Oncology Therapeutics Inc. | BBOT | $2.95 | 1.55% | 474 | 430 | $237 | $12.31 | -76.04% |
| Dyne Therapeutics, Inc. | DYN | $15.29 | 1.66% | 2,075 | 2,002 | $2,855 | $19.59 | -21.95% |
| CytomX Therapeutics, Inc. | CTMX | $2.41 | 8.07% | 2,985 | 4,255 | $525 | $1.13 | 113.27% |
| Serina Therapeutics, Inc. | SER | $1.79 | 4.68% | 27 | 90 | $27 | $2.15 | -16.74% |
| LENZ Therapeutics, Inc. | LENZ | $3.57 | 4.08% | 794 | 900 | $112 | $16.31 | -78.11% |
| Oncolytics Biotech Inc. | ONCY | $0.55 | 1.75% | 1,296 | 1,524 | $55 | $0.96 | -42.71% |
| BriaCell Therapeutics Corp. | BCTX | $3.77 | 2.03% | 34 | 203 | $33 | $7.23 | -47.86% |
| Protara Therapeutics, Inc. | TARA | $2.40 | -3.23% | 862 | 716 | $142 | $6.14 | -60.91% |
| Allogene Therapeutics, Inc. | ALLO | $1.34 | 3.08% | 4,515 | 8,034 | $463 | $2.24 | -40.18% |
| Pulse Biosciences, Inc. | PLSE | $45.59 | -1.58% | 426 | 352 | $3,252 | $19.63 | 132.25% |
| Sutro Biopharma, Inc. | STRO | $11.46 | 8.94% | 418 | 357 | $190 | $19.50 | -41.23% |
| ALX Oncology Holdings Inc. | ALXO | $1.00 | 11.77% | 3,709 | 1,306 | $138 | $1.13 | -11.50% |
| Erasca, Inc. | ERAS | $14.87 | 1.16% | 8,481 | 6,695 | $5,201 | $3.71 | 300.81% |
| Adlai Nortye Ltd. | ANL | $12.09 | 11.12% | 864 | 225 | $642 | $2.30 | 425.65% |
| Aquestive Therapeutics, Inc. | AQST | $4.06 | -11.93% | 5,454 | 0 | $510 | $3.58 | 13.41% |
| Arcturus Therapeutics Holdings Inc. | ARCT | $11.27 | 1.35% | 493 | 0 | $320 | $17.94 | -37.18% |
| Zura Bio Limited | ZURA | $4.28 | -2.95% | 4,990 | 0 | $410 | $2.58 | 65.89% |
| ArriVent BioPharma, Inc. | AVBP | $16.79 | 3.64% | 815 | 0 | $828 | $20.79 | -19.24% |
